Neema Mturi/Lancet Infect Dis

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.Hamaluba, M. van der Pluijm, R. W. Weya, J. Njuguna, P. Ngama, M. Kalume, P. Mwambingu, G. Ngetsa, C. Wambua, J. Boga, M. Mturi, N. Lal, A. A. Khuroo, A. Taylor, W. R. J. Goncalves, S. Miotto, O. Dhorda, M. Mutinda, B. Mukaka, M. Waithira, N. Hoglund, R. M. Imwong, M. Tarning, J. Day, N. P. J. White, N. J. Bejon, P. Dondorp, A. M.
Lancet Infect Dis, (2021). 21:1395-1406

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.Olotu, A. Lusingu, J. Leach, A. Lievens, M. Vekemans, J. Msham, S. Lang, T. Gould, J. Dubois, M. C. Jongert, E. Vansadia, P. Carter, T. Njuguna, P. Awuondo, K. O. Malabeja, A. Abdul, O. Gesase, S. Mturi, N. Drakeley, C. J. Savarese, B. Villafana, T. Lapierre, D. Ballou, W. R. Cohen, J. Lemnge, M. M. Peshu, N. Marsh, K. Riley, E. M. von Seidlein, L. Bejon, P.
Lancet Infect Dis, (2011). 11:102-9